Liver function and drug levels: a closer look at imlunestrant

NCT ID NCT05440344

First seen Nov 12, 2025 · Last updated Apr 30, 2026 · Updated 17 times

Summary

This study looked at how imlunestrant enters the blood and leaves the body in women with and without liver problems. 27 women took part to help researchers understand the drug's behavior. The goal was not to treat a disease but to gather important safety and dosing information.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • American Research Corporation at Texas Liver Institute

    San Antonio, Texas, 78215, United States

  • Inland Empire Liver Foundation

    Rialto, California, 92377, United States

  • Orlando Clinical Research Center

    Orlando, Florida, 32809, United States

Conditions

Explore the condition pages connected to this study.